CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Cybin Conference: Helus CEO Eyes Q4 Phase III Depression Data for HLP003

Phase 3HLP003Positive
AI Analysis

Summary

Helus CEO announced that Phase III depression data for HLP003 is expected in Q4 2026. The company is presenting at the Cybin Conference regarding this upcoming milestone.

Clinical Trial Data

Phase

Phase III

Importance:7/10
Sentiment:
0.50
Phase_3DepressionHLP003Data_Expected
Related Companies

Read the original article

Published by yahoo_finance on August 14, 2026 11:04 AM

Read Original